Author

Wayne Nicholls

Children's Health Queensland Hospital and Health ServiceORCID 0000-0003-0926-526XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Chelsea MayohiD· 2 shared David Simon ZiegleriD· 2 shared Loretta M. S. LauiD· 2 shared Marie WongiD· 2 shared Mark J. CowleyiD· 2 shared Michelle HaberiD· 2 shared Pamela AjuyahiD· 2 shared Paul G. EkertiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Chelsea MayohORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedMar 18, 2026

Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across pediatric and AYA sarcomas

Ashleigh M. Fordham, Lauren M. Brown, Chelsea Mayoh…·Emmy D.G. Fleuren

The paper identifies FGFR aberrations as actionable targets in pediatric and AYA sarcomas using multi-platform profiling and shows FGFR inhibitors can inhibit tumor growth in PDX models.

1 citation

humanwhole-genome sequencing

𝕏 PostBluesky

GenomicsbioRxivPreprintJun 25, 2025

Expanding the utility of transcriptome analysis for mutation detection in high-risk childhood precision oncology

Chelsea Mayoh, Paulette Barahona, Angela Lin…·Mark J. Cowley

This paper shows RNA-seq can detect most mutations found by WGS in pediatric tumors and provides additional insights into their pathogenicity.

DOI 10.1101/2025.06.25.661445

humanbulk RNA-seq

𝕏 PostBluesky